Resources
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
Check the spelling in your query or search for a new term.
Site search accepts advanced operators to help refine your query. Learn more.
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
CAS has completed a project with The National Institute of Industrial Property (INPI) of Brazil for an enhanced examination workflow solution for chemistry patent applications using a unique blend of technology, artificial intelligence, data, and expertise. The new solution reduced application examination times by up to 50%, and helped to reduce their multi-year application backlog.
The world’s most trusted source for scientific information, CAS, leverages new content, technologies, and expertise to advance its life sciences growth initiative.
Drawing on the CAS Content Collection and scientific expertise, CAS Insights offers business and research leaders perspectives on the latest developments across science and technology.
CAS drives Increase in R&D productivity with launch of breakthrough Retrosynthesis Planner in SciFinder-n. This
unites advanced technology with CAS’s unmatched collection of chemical reaction data to increase efficiency of chemical synthesis planning.
This collaboration leverages a tailored CAS Custom Services solution designed on a foundation of specialized CAS technologies, data science, and the CAS Content Collection to empower efficiencies in Dow’s research processes.
Through the CAS Innovation Incubator, CAS offers resources, expertise, and potential funding to early-stage innovators to help boost their science-based ventures.
CAS collaborated with MIT to accelerate research on chemical synthesis planning. CAS will provide MIT with scientist-curated data for AI training.
CAS is launching a collaboration with Mana.bio to enrich their proprietary database to fuel its AI engine, with an expected 70% reduction in resources allocated to molecular data acquisition and preparation.
The CAS SciFinder Discovery Platform redefines its role in drug discovery with the inclusion of unique biosequence data collection and capabilities.